John Burn
Burn, John, MD, MRCP
VIAF ID: 55834957 (Personal)
Permalink: http://viaf.org/viaf/55834957
Preferred Forms
-
100 1 _ ‡a Burn, John, ‡c MD, MRCP
-
100 1 _
‡a
Burn, John,
‡c
MD, MRCP
-
100 0 _
‡a
John Burn
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| The Gemini inheritance [VR] c1990: |
|
| Harveian Oration and dinner : prediction and prevention in the genomic era, 2019: |
|
| Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial |
|
| Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy |
|
| Lynch syndrome: history, causes, diagnosis, treatment and prevention (CAPP2 trial). |
|
| Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic |
|
| The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome |
|
| Maternal serum screening for Down's syndrome: a survey of midwives' views |
|
| May spina bifida result from an X-linked defect in a selective abortion mechanism? |
|
| Meckel syndrome: what are the minimum diagnostic criteria? |
|
| Medical directory, 1992: |
|
| Methylenetetrahydrofolate reductase and neural tube defects |
|
| MLH1 Differential Allelic Expression in Mutation Carriers and Controls |
|
| An MLH1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH1 |
|
| Molecular characterization of the spectrum of genomic deletions in the mismatch repair genesMSH2,MLH1,MSH6, andPMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC) |
|
| Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome |
|
| Monozygotic twins with chromosome 22q11 deletion and discordant phenotype |
|
| Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality |
|
| Mutation detection in exons 1-14 of the adenomatous polyposis coli gene: identification of an alternatively spliced transcript. |
|
| Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease |
|
| Mutation (variation) databases and registries: a rationale for coordination of efforts |
|
| Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth |
|
| Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus |
|
| Neural tube defects as an X-linked condition |
|
| Neuroferritinopathy: a window on the role of iron in neurodegeneration. |
|
| Neuroferritinopathy in a French family with late onset dominant dystonia |
|
| Neuropathological and biochemical investigation of Hereditary Ferritinopathycases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress |
|
| New dysmorphic syndrome with choanal atresia in siblings |
|
| No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in and : A Prospective Lynch Syndrome Database Study |
|
| The North Cumbria Community Genetics Project |
|
| A novel FTL insertion causing neuroferritinopathy |
|
| A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumours |
|
| Peutz-Jeghers syndrome: a systematic review and recommendations for management |
|
| Planning the human variome project: the Spain report. |
|
| Point of care testing for improving risk- benefit ratio of aspirin and warfarin |
|
| Polymorphisms of the DNA repair gene XRCC1 and the frequency of somatic mutations at the glycophorin A locus in newborns |
|
| The poor patient with diabetes ‘should live like a saint’ |
|
| Population based, prospective study of the care of women with epilepsy in pregnancy |
|
| Population frequencies of three DNA alleles linked to the Duchenne muscular dystrophy gene. |
|
| Population screening in cystic fibrosis |
|
| PPM-X: a new X-linked mental retardation syndrome with psychosis, pyramidal signs, and macroorchidism maps to Xq28 |
|
| Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients. |
|
| Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. |
|
| Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation |
|
| Primidone teratogenicity or noonan syndrome? |
|
| Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis |
|
| The protocol for a european double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: The capp study |
|
| RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies |
|
| A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes. |
|
| RE: Correspondence from Wieczorek & Gillessen-Kaesbach and Hing & Parisi |
|
| Recognition of clinical genetics in Europe |
|
| Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. |
|
| Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study |
|
| Refinement of the NHS locus on chromosome Xp22.13 and analysis of five candidate genes |
|
| Relevance of the Human Genome Project to inherited metabolic disease |
|
| Reply to Burn and Sheth |
|
| Reply to Howlett and Mortimer |
|
| The role of aspirin in preventing colorectal cancer |
|
| Scoliosis in association with infantile hypophosphatasia: a case study in two siblings |
|
| A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes |
|
| Sequencing-based microsatellite instability testing using as few as six markers for high-throughput clinical diagnostics |
|
| Should we sequence everyone's genome? Yes. |
|
| Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype |
|
| Smith-Lemli-Opitz syndromes: Do they include the Pallister-Hall syndrome? |
|
| Spectrum of movement disorders in neuroferritinopathy |
|
| Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations |
|
| Survey of HNPCC Management Analysis of Responses from 18 International Cancer Centres |
|
| Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report |
|
| Susceptibility markers in colorectal cancer. |
|
| Susceptibility to spina bifida; an association study of five candidate genes |
|
| Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. |
|
| Terathanasia, folic acid, and birth defects |
|
| A terminal deletion of the long arm of chromosome 4 [46,XX,del(4)(q33)] in an infant with phenotypic features of Williams syndrome. |
|
| Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism |
|
| Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom |
|
| Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects |
|
| Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression |
|
| Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial |
|
| The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations |
|
| The "unnatural" history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance |
|
| An unusual gait following the discovery of a new disease |
|
